ieumBio has been selected for Phase 1 of the Tech Launch 2026 program by Korea Innovation Center Washington DC.

This program supports high-potential startups in entering the US market and connecting with global partners and investors.

Through this opportunity, we aim to accelerate our expansion into the US and further validate our platform in the global longevity and biotech ecosystem.

We look forward to engaging with partners and stakeholders as we take the next step in our global journey.

If you're based in the US and interested in collaboration, let’s connect.

#startup #globalexpansion #biotech #longevity #innovation #USmarket #venture